Carlos F. Barbas

54.0k total citations · 13 hit papers
368 papers, 44.8k citations indexed

About

Carlos F. Barbas is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Carlos F. Barbas has authored 368 papers receiving a total of 44.8k indexed citations (citations by other indexed papers that have themselves been cited), including 238 papers in Molecular Biology, 149 papers in Organic Chemistry and 143 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carlos F. Barbas's work include Monoclonal and Polyclonal Antibodies Research (143 papers), Asymmetric Synthesis and Catalysis (94 papers) and Chemical Synthesis and Analysis (79 papers). Carlos F. Barbas is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (143 papers), Asymmetric Synthesis and Catalysis (94 papers) and Chemical Synthesis and Analysis (79 papers). Carlos F. Barbas collaborates with scholars based in United States, Japan and Portugal. Carlos F. Barbas's co-authors include Richard A. Lerner, Fujie Tanaka, Thomas Gaj, Wolfgang Notz, Benjamin List, Charles A. Gersbach, Bin Tan, Dennis R. Burton, Roger R. Beerli and Tommy Bui and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Carlos F. Barbas

366 papers receiving 43.7k citations

Hit Papers

ZFN, TALEN, and CRISPR/Ca... 1991 2026 2002 2014 2013 2000 2004 2001 1991 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
    2013 2.7k citations Thomas Gaj, Charles A. Gersbach et al. profile →
  2. Proline-Catalyzed Direct Asymmetric Aldol Reactions
    2000 2.4k citations Benjamin List, Richard A. Lerner et al. profile →
  3. Enamine-Based Organocatalysis with Proline and Diamines:  The Development of Direct Catalytic Asymmetric Aldol, Mannich, Michael, and Diels−Alder Reactions
    2004 1.2k citations Fujie Tanaka, Carlos F. Barbas et al. profile →
  4. Amino Acid Catalyzed Direct Asymmetric Aldol Reactions:  A Bioorganic Approach to Catalytic Asymmetric Carbon−Carbon Bond-Forming Reactions
    2001 1.0k citations Tommy Bui, Carlos F. Barbas et al. profile →
  5. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.
    1991 950 citations Carlos F. Barbas, Richard A. Lerner et al. Proceedings of the National Academy of Sciences profile →
  6. Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
    1994 938 citations Carlos F. Barbas et al. profile →
  7. De Novo Computational Design of Retro-Aldol Enzymes
    2008 890 citations Fujie Tanaka, Carlos F. Barbas et al. profile →
  8. Organocatalytic Asymmetric Assembly Reactions: Synthesis of Spirooxindoles via Organocascade Strategies
    2014 780 citations Bin Tan, Carlos F. Barbas et al. profile →
  9. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
    2003 777 citations Roger R. Beerli, Carlos F. Barbas et al. Proceedings of the National Academy of Sciences profile →
  10. Phage Display : A Laboratory Manual
    2001 740 citations Carlos F. Barbas profile →
  11. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
    1991 555 citations Carlos F. Barbas et al. Proceedings of the National Academy of Sciences profile →
  12. Organocatalytic Direct Asymmetric Aldol Reactions in Water.
    2006 523 citations Nobuyuki Mase, Fujie Tanaka et al. ChemInform profile →
  13. Immune Versus Natural Selection: Antibody Aldolases with Enzymic Rates But Broader Scope
    1997 333 citations Carlos F. Barbas, Guofu Zhong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos F. Barbas United States 108 23.4k 20.4k 8.8k 4.9k 3.9k 368 44.8k
M. G. Finn United States 83 22.1k 0.9× 28.4k 1.4× 5.2k 0.6× 1.4k 0.3× 919 0.2× 274 46.6k
Stephen J. Benkovic United States 84 20.8k 0.9× 3.2k 0.2× 2.2k 0.3× 952 0.2× 598 0.2× 457 28.6k
Carolyn R. Bertozzi United States 122 43.3k 1.8× 31.0k 1.5× 11.0k 1.2× 432 0.1× 5.2k 1.3× 501 62.3k
Stephen B. H. Kent United States 77 22.2k 0.9× 9.3k 0.5× 2.9k 0.3× 130 0.0× 1.6k 0.4× 261 29.0k
Valery V. Fokin United States 76 18.5k 0.8× 33.3k 1.6× 3.7k 0.4× 1.6k 0.3× 530 0.1× 185 40.7k
Horst Kessler Germany 103 22.8k 1.0× 9.9k 0.5× 6.0k 0.7× 963 0.2× 2.2k 0.6× 764 44.0k
Samuel J. Danishefsky United States 97 19.9k 0.9× 33.4k 1.6× 1.7k 0.2× 1.8k 0.4× 1.3k 0.3× 850 41.6k
Andrew D. Hamilton United States 92 17.3k 0.7× 10.0k 0.5× 1.1k 0.1× 1.5k 0.3× 938 0.2× 447 30.1k
Fernando Alberício Spain 85 20.0k 0.9× 14.9k 0.7× 1.9k 0.2× 891 0.2× 1.2k 0.3× 935 30.7k
T. Alwyn Jones Sweden 66 21.1k 0.9× 1.8k 0.1× 1.1k 0.1× 573 0.1× 2.4k 0.6× 181 29.7k

Countries citing papers authored by Carlos F. Barbas

Since Specialization
Citations

This map shows the geographic impact of Carlos F. Barbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos F. Barbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos F. Barbas more than expected).

Fields of papers citing papers by Carlos F. Barbas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos F. Barbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos F. Barbas. The network helps show where Carlos F. Barbas may publish in the future.

Co-authorship network of co-authors of Carlos F. Barbas

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos F. Barbas. A scholar is included among the top collaborators of Carlos F. Barbas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos F. Barbas. Carlos F. Barbas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aguiar, Sandra I., Joana Dias, Marta Silva, et al.. (2021). Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening. Pharmaceutics. 13(10). 1598–1598. 21 indexed citations
2.
Patterson, James T, Shigehiro Asano, Roberta Fuller, et al.. (2016). Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation. Bioconjugate Chemistry. 27(10). 2271–2275. 18 indexed citations
3.
Gaj, Thomas, et al.. (2016). Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors. PLoS ONE. 11(3). e0150037–e0150037. 11 indexed citations
4.
Gaj, Thomas, et al.. (2014). Protein Delivery Using Cys 2 –His 2 Zinc-Finger Domains. ACS Chemical Biology. 9(8). 1662–1667. 48 indexed citations
5.
Gersbach, Charles A., Thomas Gaj, & Carlos F. Barbas. (2014). Comparing Genome Editing Technologies. Genetic Engineering & Biotechnology News. 34(5). 1, 32–34. 1 indexed citations
6.
Toda, Narihiro, Shigehiro Asano, & Carlos F. Barbas. (2013). Rapid, Stable, Chemoselective Labeling of Thiols with Julia–Kocieński‐like Reagents: A Serum‐Stable Alternative to Maleimide‐Based Protein Conjugation. Angewandte Chemie International Edition. 52(48). 12592–12596. 171 indexed citations
7.
Tan, Bin, Xiaofei Zeng, Wendy Wen Yi Leong, et al.. (2011). Core Structure‐Based Design of Organocatalytic [3+2]‐Cycloaddition Reactions: Highly Efficient and Stereocontrolled Syntheses of 3,3′‐Pyrrolidonyl Spirooxindoles. Chemistry - A European Journal. 18(1). 63–67. 100 indexed citations
8.
González, Beatríz, et al.. (2010). Modular system for the construction of zinc-finger libraries and proteins. Nature Protocols. 5(4). 791–810. 71 indexed citations
9.
Blancafort, Pilar, Mario P. Tschan, Daniel Guthy, et al.. (2008). Modulation of drug resistance by artificial transcription factors. Molecular Cancer Therapeutics. 7(3). 688–697. 20 indexed citations
10.
Shamis, Marina, Carlos F. Barbas, & Doron Shabat. (2006). A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity. Bioorganic & Medicinal Chemistry Letters. 17(5). 1172–1175. 10 indexed citations
11.
Popkov, Mikhail, et al.. (2005). Targeting Tumor Angiogenesis with Adenovirus-Delivered Anti-Tie-2 Intrabody. Cancer Research. 65(3). 972–981. 54 indexed citations
12.
Chowdari, Naidu S. & Carlos F. Barbas. (2005). Total Synthesis of LFA‐1 Antagonist BIRT‐377 via Organocatalytic Asymmetric Construction of a Quaternary Stereocenter.. ChemInform. 36(29). 2 indexed citations
13.
Lund, Caren V., Mikhail Popkov, Laurent Magnenat, & Carlos F. Barbas. (2005). Zinc Finger Transcription Factors Designed for Bispecific Coregulation of ErbB2 and ErbB3 Receptors: Insights into ErbB Receptor Biology. Molecular and Cellular Biology. 25(20). 9082–9091. 14 indexed citations
14.
Gräslund, Torbjörn, Xuelin Li, Laurent Magnenat, Mikhail Popkov, & Carlos F. Barbas. (2004). Exploring Strategies for the Design of Artificial Transcription Factors. Journal of Biological Chemistry. 280(5). 3707–3714. 69 indexed citations
15.
Mase, Nobuyuki, Fujie Tanaka, & Carlos F. Barbas. (2004). Synthesis of β‐Hydroxyaldehydes with Stereogenic Quaternary Carbon Centers by Direct Organocatalytic Asymmetric Aldol Reactions. Angewandte Chemie. 116(18). 2474–2477. 70 indexed citations
16.
Berry, Jody D., John D. Rutherford, Gregg J. Silverman, et al.. (2003). Development of Functional Human Monoclonal Single-Chain Variable Fragment Antibody Against HIV-1 from Human Cervical B Cells. PubMed. 22(2). 97–108. 8 indexed citations
17.
Berry, Jody D., et al.. (2003). Rapid Monoclonal Antibody Generation Via Dendritic Cell Targeting In Vivo. PubMed. 22(1). 23–31. 16 indexed citations
18.
Dreier, Birgit, Roger R. Beerli, David J. Segal, Jessica Flippin, & Carlos F. Barbas. (2001). Development of Zinc Finger Domains for Recognition of the 5′-ANN-3′ Family of DNA Sequences and Their Use in the Construction of Artificial Transcription Factors. Journal of Biological Chemistry. 276(31). 29466–29478. 273 indexed citations
19.
Turner, James M., Tommy Bui, Richard A. Lerner, Carlos F. Barbas, & Benjamin List. (2000). An Efficient Benchtop System for Multigram-Scale Kinetic Resolutions Using Aldolase Antibodies. Chemistry - A European Journal. 6(15). 2772–2774. 35 indexed citations
20.
Beerli, Roger R., David J. Segal, Birgit Dreier, & Carlos F. Barbas. (1998). Toward controlling gene expression at will: Specific regulation of the erbB - 2 / HER - 2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proceedings of the National Academy of Sciences. 95(25). 14628–14633. 412 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. G. Finn Breakdown of academic impact, for papers by Stephen J. Benkovic Breakdown of academic impact, for papers by Carolyn R. Bertozzi Breakdown of academic impact, for papers by Stephen B. H. Kent Breakdown of academic impact, for papers by Valery V. Fokin Breakdown of academic impact, for papers by Horst Kessler Breakdown of academic impact, for papers by Samuel J. Danishefsky Breakdown of academic impact, for papers by Andrew D. Hamilton Breakdown of academic impact, for papers by Fernando Alberício Breakdown of academic impact, for papers by T. Alwyn Jones
Rankless by CCL
2026